Skip to content

A Study of Changes in Cough Strength Induced by Inspiratory Muscle Training in Hospitalised Dialysis Patients

A Study of Changes in Cough Strength Induced by Inspiratory Muscle Training in Hospitalised Dialysis Patients - A Study of Changes in Cough Strength Induced by Inspiratory Muscle Training in Hospitalised Dialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061243
Enrollment
64
Registered
2026-04-14
Start date
2026-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

In this study, the IMT group consists of participants who undergo inspiratory muscle training using the POWERbreathe, a respiratory muscle training device, with the aim of improving inspiratory muscle
although participants use the POWERbreathe device, the intervention is conducted under conditions where no substantial training load is applied. The pressure is set to 10 mmHg, the minimum value for t

Sponsors

Gunma University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing maintenance haemodialysis who are currently admitted to Hidaka Rehabilitation Hospital, Hidaka Medical Corporation 2) Patients who are adults (in principle, aged 18 years or over) at the time of study enrolment 3) Patients who are able to sit independently and who can undergo IMT and respiratory function tests whilst understanding instructions 4) Patients who have been undergoing dialysis for at least three months 5) Patients from whom written informed consent has been obtained regarding participation in the study

Exclusion criteria

Exclusion criteria: 1) Patients in the acute phase of serious heart conditions, such as acute heart failure or acute coronary syndrome 2) Patients with traumatic pneumothorax or rib fractures that have not fully healed 3) Patients with asthma that frequently relapses 4) Patients with injuries such as a perforated eardrum 5) Patients with a marked increase in left ventricular end-diastolic volume and left ventricular end-diastolic pressure 6) Patients with abdominal hernias 7) Patients who have developed pneumonia or an acute respiratory infection within the last four weeks and whose condition is not stable 8) Patients who have difficulty understanding instructions or coughing safely due to severe cognitive impairment or dysphagia 9) Other patients deemed unsuitable for participation in this study by the principal investigator or a co-investigator [Rationale for Exclusion Criteria] 1) to 7) From a safety perspective, as these patients are considered to be at high risk of deterioration due to the intervention or measurements. 8) As compliance with measurement and intervention procedures is difficult, which may affect data reliability and safety. 9) To rule out the possibility that participation in the study may be detrimental, based on individual medical judgement.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is an analysis of the difference in changes in cough force (PCF) between the IMT intervention group and the sham group in patients with HD.

Countries

Japan

Contacts

Public ContactHITOSHI KUBOTA

Hidaka Rehabilitation Hospital Plastic Surgery

nikexero@gmail.com027-388-2005

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026